Invention Grant
US08669072B2 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
有权
用于通过蜕皮激素受体复合物调节外源基因表达的恶二唑啉配体
- Patent Title: Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
- Patent Title (中): 用于通过蜕皮激素受体复合物调节外源基因表达的恶二唑啉配体
-
Application No.: US11838090Application Date: 2007-08-13
-
Publication No.: US08669072B2Publication Date: 2014-03-11
- Inventor: Robert Eugene Hormann , Orestes Chortyk , Dat Phat Le
- Applicant: Robert Eugene Hormann , Orestes Chortyk , Dat Phat Le
- Applicant Address: US VA Blacksburg
- Assignee: Intrexon Corporation
- Current Assignee: Intrexon Corporation
- Current Assignee Address: US VA Blacksburg
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: C12P21/02
- IPC: C12P21/02

Abstract:
The present invention relates to non-steroidal ligands for use in nuclear receptor-based inducible gene expression system, and a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene.
Public/Granted literature
- US20070287731A1 OXADIAZOLINE LIGANDS FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX Public/Granted day:2007-12-13
Information query